Literature DB >> 21103870

The rising PET: the increasing use of choline PET/CT in prostate cancer.

Arturo Chiti, Maria Picchio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21103870     DOI： 10.1007/s00259-010-1662-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Radionuclide and hybrid imaging of recurrent prostate cancer.

Authors:  Ambros J Beer; Matthias Eiber; Michael Souvatzoglou; Markus Schwaiger; Bernd Joachim Krause
Journal:  Lancet Oncol       Date:  2010-07-06       Impact factor: 41.316

Review 2.  The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

Authors:  Maria Picchio; Alberto Briganti; Stefano Fanti; Axel Heidenreich; Bernd J Krause; Cristina Messa; Francesco Montorsi; Sven N Reske; George N Thalmann
Journal:  Eur Urol       Date:  2010-09-15       Impact factor: 20.096

3.  Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

Authors:  Paolo Castellucci; Chiara Fuccio; Domenico Rubello; Riccardo Schiavina; Ivan Santi; Cristina Nanni; Vincenzo Allegri; Gian Carlo Montini; Valentina Ambrosini; Stefano Boschi; Giuseppe Martorana; Maria Cristina Marzola; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-17       Impact factor: 9.236

4.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

Review 5.  A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence.

Authors:  M J Beresford; D Gillatt; R J Benson; T Ajithkumar
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-11-30       Impact factor: 4.126
  5 in total
  5 in total

1.  Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.

Authors:  Huojun Zhang; Wei Xing; Qinqin Kang; Chao Chen; Linhui Wang; Jianping Lu
Journal:  Tumour Biol       Date:  2015-03-26

Review 2.  F18-choline/C11-choline PET/CT thyroid incidentalomas.

Authors:  Francesco Bertagna; Domenico Albano; Luca Giovanella; Raffaele Giubbini; Giorgio Treglia
Journal:  Endocrine       Date:  2019-01-12       Impact factor: 3.633

3.  11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml.

Authors:  Giampiero Giovacchini; Priscilla Guglielmo; Paola Mapelli; Elena Incerti; Ana Maria Samanes Gajate; Elisabetta Giovannini; Mattia Riondato; Alberto Briganti; Luigi Gianolli; Andrea Ciarmiello; Maria Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-10       Impact factor: 9.236

Review 4.  Application of metabolic PET imaging in radiation oncology.

Authors:  Aizhi Zhu; David M Marcus; Hui-Kuo G Shu; Hyunsuk Shim
Journal:  Radiat Res       Date:  2012-02-17       Impact factor: 2.841

5.  Transbilayer phospholipids molecular imaging.

Authors:  Tarik Z Belhocine; Frank S Prato
Journal:  EJNMMI Res       Date:  2011-08-22       Impact factor: 3.138
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.